Completed PHASE3 INTERVENTIONAL 4-arm NCT00063453

Supplemental Selenium and Vitamin E and Pulmonary Function

The Respiratory Ancillary Study (RAS) to SELECT

Sponsor: Cornell University

Conditions Chronic Obstructive Pulmonary Disease Lung Diseases Lung Diseases, Obstructive

Interventions Selenium Selenium placebo Vitamin E Vitamin E placebo

Updated 6 times since 2017 Last updated: Dec 8, 2017 Started: Aug 31, 2003 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Chronic Obstructive Pulmonary Disease and Lung Diseases and is currently completed. Cornell University leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Dec 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Dec 2017 [monthly]

Completed PHASE3

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cornell University
National Heart, Lung, and Blood Institute (NHLBI)

Data source: Cornell University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.